Westpac Banking Corp’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-7,624
| Closed | -$348K | – | 901 |
|
|
2017
Q1 | $348K | Sell |
7,624
-14
| -0.2% | -$638 | ﹤0.01% | 869 |
|
|
2016
Q4 | $247K | Buy |
7,638
+70
| +0.9% | +$2.26K | ﹤0.01% | 802 |
|
|
2016
Q3 | $259K | Buy |
7,568
+1,691
| +29% | +$57.9K | ﹤0.01% | 770 |
|
|
2016
Q2 | $198K | Buy |
5,877
+1,870
| +47% | +$63.1K | ﹤0.01% | 843 |
|
|
2016
Q1 | $212K | Buy |
4,007
+153
| +4% | +$8.11K | ﹤0.01% | 795 |
|
|
2015
Q4 | $296K | Buy |
3,854
+151
| +4% | +$11.6K | ﹤0.01% | 773 |
|
|
2015
Q3 | $152K | Buy |
3,703
+1,417
| +62% | +$58.2K | ﹤0.01% | 811 |
|
|
2015
Q2 | $162K | Buy |
2,286
+31
| +1% | +$2.19K | ﹤0.01% | 682 |
|
|
2015
Q1 | $200K | Buy |
2,255
+587
| +35% | +$52.2K | ﹤0.01% | 889 |
|
|
2014
Q4 | $148K | Buy |
1,668
+1,042
| +166% | +$92.4K | ﹤0.01% | 908 |
|
|
2014
Q3 | $60.7K | Buy |
+626
| New | +$60.7K | ﹤0.01% | 921 |
|